Dr. Richard William Hamilton, Ph.D. has been appointed as Director of the Company, effective February 28, 2017. Dr. Hamilton, served as President and Chief Executive Officer of Ceres Inc. from September 2002 until Ceres’ acquisition by Land O’Lakes, Inc. in August 2016. He served as Ceres’ Chief Financial Officer from 1998 until September 2002, at which time he was appointed President and Chief Executive Officer. He served on Ceres’ Board of Directors from 2002 - 2016. In addition to his leadership role at Ceres, Dr. Hamilton has sat on the Keck Graduate Institute Advisory Council and he was a founding member of the Council for Sustainable Biomass Production. He has served on the U.S. Department of Energy’s Biomass Research and Development Technical Advisory Committee and has been active in the Biotechnology Industry Organization where he has served as Vice Chairman of the organization, chaired its Food and Agriculture Governing Board and served in other leadership roles. From 1996 to 1998, Dr. Hamilton was a Principal at Oxford Bioscience Partners, one of the leading investors in the genomics field and a founder of Ceres. He was an Associate at Boston-based MVP Ventures from 1993 to1996. From 1990 to 1992, he was a Howard Hughes Medical Institute Research Fellow at Harvard Medical School. Dr. Hamilton holds a Ph.D. in molecular biology from Vanderbilt University and a B.S. in biology from St. Lawrence University.
Richard Hamilton is 54, he's been the Director of Yield10 Bioscience Inc since 2017. There are 5 older and 2 younger executives at Yield10 Bioscience Inc. The oldest executive at Yield10 Bioscience Inc is Anthony Sinskey, 77, who is the Independent Director.
Richard's mailing address filed with the SEC is C/O YIELD10 BIOSCIENCE, 19 PRESIDENTIAL WAY, SUITE 201, WOBURN, MA, 01801.
Over the last 8 years, insiders at Yield10 Bioscience Inc have traded over $1,212,006 worth of Yield10 Bioscience Inc stock and bought 4,271,174 units worth $10,113,836 . The most active insiders traders include Jack W Schuler, Peter N Kellogg und Joseph H Shaulson. On average, Yield10 Bioscience Inc executives and independent directors trade stock every 107 days with the average trade being worth of $238,638. The most recent stock trade was executed by Jack W Schuler on 20 December 2023, trading 36,000 units of YTEN stock currently worth $7,200.
yield10 bioscience, inc., an agricultural bioscience company, engages in developing disruptive technologies for step-changing improvements in crop yield in the united states and canada. the company, through its trait factory, is involved in developing high value seed traits for the agriculture and food industries. it also has an oilseed development center in saskatchewan, canada. yield10 bioscience, inc. has research agreements with bayer ag to develop traits in soybean; forage genetics international, llc to develop traits in forage sorghum; j. r. simplot company to develop novel traits in potato; and gdm seeds inc. to evaluate yield traits in soybeans. the company was formerly known as metabolix, inc. and changed its name to yield10 bioscience, inc. in january 2017. yield10 bioscience, inc. was founded in 1992 and is headquartered in woburn, massachusetts.
Yield10 Bioscience Inc executives and other stock owners filed with the SEC include: